Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective Effect of Dexmedetomidine in Elderly Surgery Patients
NCT04973124Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Nov 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) (2 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Default Mode Network Integrity. Started Nov 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04973124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04973124.